Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 10,725 shares at $47.91 ($511K) on 2011-02-28, disclosed to the SEC on 2011-03-02.
Scheduled sale ($511k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.64 | 9,161 | $436K | 85.3% |
| 2 | $47.91 | 1,564 | $75K | 14.7% |
| Total | $47.68 avg | 10,725 | $511K | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-02-10 | $2.4M | — | Filing → |